Recently, telerehabilitation has taken on a significant role in rehabilitation programs, with benefits in improving balance. Many neurological diseases are associated with an increased fall risk and, considering the impact of falls on quality of life, the aim of this study is to evaluate the ability of the Silver Index (via the hunova® robotic platform) to identify the fall risk and the effect of a telerehabilitation intervention (by ARC Intellicare) on fall risk in patients with neurological disorders. This is an ancillary study of a single-center, randomized controlled trial. Ninety patients with stroke, Multiple Sclerosis (MS), and Parkinson’s Disease (PD) participated, and were randomized into an ARC Intellicare group (experimental group) and a paper-based group (control group). Each group performed home treatment for 60 min a day, 3 days a week, for 8 weeks. Fall risk was assessed with clinical scales and hunova®. Data analysis showed a correlation between clinical scales and the Silver Index. Furthermore, only the MS patients in the experimental group showed a significant decrease in fall risk (p = 0.015). This study suggested that the Silver Index is a valid tool for assessing fall risk in neurological disorders. It also confirmed that ARC Intellicare is a useful tool for remote rehabilitation at home.

Castelli, L., Iacovelli, C., Malizia, A. M., Loreti, C., Biscotti, L., Bentivoglio, A. R., Calabresi, P., Giovannini, S., A New Assessment Tool for Risk of Falling and Telerehabilitation in Neurological Diseases: A Randomized Controlled Ancillary Study, <<APPLIED SCIENCES>>, 2025; 15 (20): N/A-N/A. [doi:10.3390/app152011247] [https://hdl.handle.net/10807/325982]

A New Assessment Tool for Risk of Falling and Telerehabilitation in Neurological Diseases: A Randomized Controlled Ancillary Study

Castelli, Letizia
Primo
;
Iacovelli, Chiara;Loreti, Claudia
;
Bentivoglio, Anna Rita;Calabresi, Paolo;Giovannini, Silvia
Ultimo
2025

Abstract

Recently, telerehabilitation has taken on a significant role in rehabilitation programs, with benefits in improving balance. Many neurological diseases are associated with an increased fall risk and, considering the impact of falls on quality of life, the aim of this study is to evaluate the ability of the Silver Index (via the hunova® robotic platform) to identify the fall risk and the effect of a telerehabilitation intervention (by ARC Intellicare) on fall risk in patients with neurological disorders. This is an ancillary study of a single-center, randomized controlled trial. Ninety patients with stroke, Multiple Sclerosis (MS), and Parkinson’s Disease (PD) participated, and were randomized into an ARC Intellicare group (experimental group) and a paper-based group (control group). Each group performed home treatment for 60 min a day, 3 days a week, for 8 weeks. Fall risk was assessed with clinical scales and hunova®. Data analysis showed a correlation between clinical scales and the Silver Index. Furthermore, only the MS patients in the experimental group showed a significant decrease in fall risk (p = 0.015). This study suggested that the Silver Index is a valid tool for assessing fall risk in neurological disorders. It also confirmed that ARC Intellicare is a useful tool for remote rehabilitation at home.
2025
Inglese
Castelli, L., Iacovelli, C., Malizia, A. M., Loreti, C., Biscotti, L., Bentivoglio, A. R., Calabresi, P., Giovannini, S., A New Assessment Tool for Risk of Falling and Telerehabilitation in Neurological Diseases: A Randomized Controlled Ancillary Study, <<APPLIED SCIENCES>>, 2025; 15 (20): N/A-N/A. [doi:10.3390/app152011247] [https://hdl.handle.net/10807/325982]
File in questo prodotto:
File Dimensione Formato  
DOC-20251020-WA0008..pdf

accesso aperto

Licenza: Creative commons
Dimensione 706.01 kB
Formato Adobe PDF
706.01 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/325982
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact